Global Changes in the Mammary Epigenome Are Induced by Hormonal Cues and Coordinated by Ezh2

Cell Reports

Volumn 3, Issue 2, 2013, Pages 411-426

  Pal, Bhupinder ^a,b   Bouras, Toula ^a,b   Shi, Wei ^a,b   Vaillant, François ^a,b   Sheridan, Julie M ^a,b   Fu, Naiyang ^a,b   Breslin, Kelsey ^a   Jiang, Kun ^a   Ritchie, Matthew E ^a,b   Young, Matthew ^a   Lindeman, Geoffrey J ^a,b,c   Smyth, Gordon K ^a,b   Visvader, Jane E ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; PROGESTERONE; TRANSCRIPTION FACTOR EZH2;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CELL ACTIVITY; CELL COUNT; CELL DIFFERENTIATION; CELL FATE; CELL POPULATION; CONTROLLED STUDY; ENZYME ACTIVITY; EPIGENETICS; EZH2 GENE; FEMALE; GENE; GENE DELETION; MAMMARY GLAND; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN MODIFICATION; STEM CELL;

ANIMALS; CELLS, CULTURED; CHROMATIN; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; HISTONES; MAMMARY GLANDS, ANIMAL; METHYLATION; MICE; PHOSPHORYLATION; POLYCOMB REPRESSIVE COMPLEX 2; POLYCOMB-GROUP PROTEINS; PREGNANCY; PROGESTERONE; STEM CELLS;

EID: 84874231902     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.12.020     Document Type: Article

References (61)

1. Asselin-Labat M.L., Sutherland K.D., Barker H., Thomas R., Shackleton M., Forrest N.C., Hartley L., Robb L., Grosveld F.G., van der Wees J., et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 2007, 9:201-209.
2. Asselin-Labat M.L., Vaillant F., Sheridan J.M., Pal B., Wu D., Simpson E.R., Yasuda H., Smyth G.K., Martin T.J., Lindeman G.J., Visvader J.E. Control of mammary stem cell function by steroid hormone signalling. Nature 2010, 465:798-802.
3. Asselin-Labat M.L., Sutherland K.D., Vaillant F., Gyorki D.E., Wu D., Holroyd S., Breslin K., Ward T., Shi W., Bath M.L., et al. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14. Mol. Cell. Biol. 2011, 31:4609-4622.
4. Bachmann I.M., Halvorsen O.J., Collett K., Stefansson I.M., Straume O., Haukaas S.A., Salvesen H.B., Otte A.P., Akslen L.A. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J. Clin. Oncol. 2006, 24:268-273.
5. Bernardo G.M., Lozada K.L., Miedler J.D., Harburg G., Hewitt S.C., Mosley J.D., Godwin A.K., Korach K.S., Visvader J.E., Kaestner K.H., et al. FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis. Development 2010, 137:2045-2054.
6. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., Fry B., Meissner A., Wernig M., Plath K., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326.
7. Bouras T., Pal B., Vaillant F., Harburg G., Asselin-Labat M.L., Oakes S.R., Lindeman G.J., Visvader J.E. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell 2008, 3:429-441.
8. Bracken A.P., Helin K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat. Rev. Cancer 2009, 9:773-784.
9. Bracken A.P., Pasini D., Capra M., Prosperini E., Colli E., Helin K. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 2003, 22:5323-5335.
10. Brisken C., O'Malley B. Hormone action in the mammary gland. Cold Spring Harb. Perspect. Biol. 2010, 2:a003178.
11. Brisken C., Park S., Vass T., Lydon J.P., O'Malley B.W., Weinberg R.A. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc. Natl. Acad. Sci. USA 1998, 95:5076-5081.
12. Caretti G., Di Padova M., Micales B., Lyons G.E., Sartorelli V. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev. 2004, 18:2627-2638.
13. Caretti G., Palacios D., Sartorelli V., Puri P.L. Phosphoryl-EZH-ion. Cell Stem Cell 2011, 8:262-265.
14. Chang C.J., Yang J.Y., Xia W., Chen C.T., Xie X., Chao C.H., Woodward W.A., Hsu J.M., Hortobagyi G.N., Hung M.C. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling. Cancer Cell 2011, 19:86-100.
15. Chen S., Bohrer L.R., Rai A.N., Pan Y., Gan L., Zhou X., Bagchi A., Simon J.A., Huang H. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat. Cell Biol. 2010, 12:1108-1114.
16. Delgado-Olguín P., Huang Y., Li X., Christodoulou D., Seidman C.E., Seidman J.G., Tarakhovsky A., Bruneau B.G. Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis. Nat. Genet. 2012, 44:343-347.
17. Doherty L.F., Bromer J.G., Zhou Y., Aldad T.S., Taylor H.S. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer. Horm. Cancer 2010, 1:146-155.
18. Ezhkova E., Pasolli H.A., Parker J.S., Stokes N., Su I.H., Hannon G., Tarakhovsky A., Fuchs E. Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell 2009, 136:1122-1135.
19. Ezhkova E., Lien W.H., Stokes N., Pasolli H.A., Silva J.M., Fuchs E. EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair. Genes Dev. 2011, 25:485-498.
20. Graham J.D., Mote P.A., Salagame U., van Dijk J.H., Balleine R.L., Huschtscha L.I., Reddel R.R., Clarke C.L. DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology 2009, 150:3318-3326.
21. Hu Y., Smyth G.K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 2009, 347:70-78.
22. Joshi P.A., Jackson H.W., Beristain A.G., Di Grappa M.A., Mote P.A., Clarke C.L., Stingl J., Waterhouse P.D., Khokha R. Progesterone induces adult mammary stem cell expansion. Nature 2010, 465:803-807.
23. Juan A.H., Derfoul A., Feng X., Ryall J.G., Dell'Orso S., Pasut A., Zare H., Simone J.M., Rudnicki M.A., Sartorelli V. Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells. Genes Dev. 2011, 25:789-794.
24. Kaneko S., Li G., Son J., Xu C.F., Margueron R., Neubert T.A., Reinberg D. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev. 2010, 24:2615-2620.
25. Keller P.J., Arendt L.M., Skibinski A., Logvinenko T., Klebba I., Dong S., Smith A.E., Prat A., Perou C.M., Gilmore H., et al. Defining the cellular precursors to human breast cancer. Proc. Natl. Acad. Sci. USA 2012, 109:2772-2777.
26. Kleer C.G., Cao Q., Varambally S., Shen R., Ota I., Tomlins S.A., Ghosh D., Sewalt R.G., Otte A.P., Hayes D.F., et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. USA 2003, 100:11606-11611.
27. Li W., Ferguson B.J., Khaled W.T., Tevendale M., Stingl J., Poli V., Rich T., Salomoni P., Watson C.J. PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. Proc. Natl. Acad. Sci. USA 2009, 106:4725-4730.
28. Lien W.H., Guo X., Polak L., Lawton L.N., Young R.A., Zheng D., Fuchs E. Genome-wide maps of histone modifications unwind in vivo chromatin states of the hair follicle lineage. Cell Stem Cell 2011, 9:219-232.
29. Lim E., Wu D., Pal B., Bouras T., Asselin-Labat M.L., Vaillant F., Yagita H., Lindeman G.J., Smyth G.K., Visvader J.E. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res. 2010, 12:R21.
30. Lydon J.P., DeMayo F.J., Funk C.R., Mani S.K., Hughes A.R., Montgomery C.A., Shyamala G., Conneely O.M., O'Malley B.W. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 1995, 9:2266-2278.
31. Mallepell S., Krust A., Chambon P., Brisken C. Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc. Natl. Acad. Sci. USA 2006, 103:2196-2201.
32. Malumbres M., Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 2009, 9:153-166.
33. Margueron R., Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature 2011, 469:343-349.
34. Maruyama R., Choudhury S., Kowalczyk A., Bessarabova M., Beresford-Smith B., Conway T., Kaspi A., Wu Z., Nikolskaya T., Merino V.F., et al. Epigenetic regulation of cell type-specific expression patterns in the human mammary epithelium. PLoS Genet. 2011, 7:e1001369.
35. Mikkelsen T.S., Ku M., Jaffe D.B., Issac B., Lieberman E., Giannoukos G., Alvarez P., Brockman W., Kim T.K., Koche R.P., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448:553-560.
36. Mueller S.O., Clark J.A., Myers P.H., Korach K.S. Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha. Endocrinology 2002, 143:2357-2365.
37. Mulac-Jericevic B., Lydon J.P., DeMayo F.J., Conneely O.M. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl. Acad. Sci. USA 2003, 100:9744-9749.
38. Narayanan R., Adigun A.A., Edwards D.P., Weigel N.L. Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator. Mol. Cell. Biol. 2005, 25:264-277.
39. Nicol J.W., Helt G.A., Blanchard S.G., Raja A., Loraine A.E. The Integrated Genome Browser: free software for distribution and exploration of genome-scale datasets. Bioinformatics 2009, 25:2730-2731.
40. Oakes S.R., Rogers R.L., Naylor M.J., Ormandy C.J. Prolactin regulation of mammary gland development. J. Mammary Gland Biol. Neoplasia 2008, 13:13-28.
41. Palacios D., Mozzetta C., Consalvi S., Caretti G., Saccone V., Proserpio V., Marquez V.E., Valente S., Mai A., Forcales S.V., et al. TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 2010, 7:455-469.
42. Pietersen A.M., Evers B., Prasad A.A., Tanger E., Cornelissen-Steijger P., Jonkers J., van Lohuizen M. Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium. Curr. Biol. 2008, 18:1094-1099.
43. Pietersen A.M., Horlings H.M., Hauptmann M., Langerød A., Ajouaou A., Cornelissen-Steijger P., Wessels L.F., Jonkers J., van de Vijver M.J., van Lohuizen M. EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer. Breast Cancer Res. 2008, 10:R109.
44. Puppe J., Drost R., Liu X., Joosse S.A., Evers B., Cornelissen-Steijger P., Nederlof P., Yu Q., Jonkers J., van Lohuizen M., Pietersen A.M. BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A. Breast Cancer Res. 2009, 11:R63.
45. Raaphorst F.M., Meijer C.J., Fieret E., Blokzijl T., Mommers E., Buerger H., Packeisen J., Sewalt R.A., Otte A.P., van Diest P.J. Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. Neoplasia 2003, 5:481-488.
46. Robinson G.W., Hennighausen L. MMTV-Cre transgenes can adversely affect lactation: considerations for conditional gene deletion in mammary tissue. Anal. Biochem. 2011, 412:92-95.
47. Rudolph M.C., McManaman J.L., Hunter L., Phang T., Neville M.C. Functional development of the mammary gland: use of expression profiling and trajectory clustering to reveal changes in gene expression during pregnancy, lactation, and involution. J. Mammary Gland Biol. Neoplasia 2003, 8:287-307.
48. Sauvageau M., Sauvageau G. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 2010, 7:299-313.
49. Sen G.L., Webster D.E., Barragan D.I., Chang H.Y., Khavari P.A. Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3. Genes Dev. 2008, 22:1865-1870.
50. Shackleton M., Vaillant F., Simpson K.J., Stingl J., Smyth G.K., Asselin-Labat M.L., Wu L., Lindeman G.J., Visvader J.E. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88.
51. Sleeman K.E., Kendrick H., Robertson D., Isacke C.M., Ashworth A., Smalley M.J. Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J. Cell Biol. 2007, 176:19-26.
52. Statham A.L., Strbenac D., Coolen M.W., Stirzaker C., Clark S.J., Robinson M.D. Repitools: an R package for the analysis of enrichment-based epigenomic data. Bioinformatics 2010, 26:1662-1663.
53. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., Li H.I., Eaves C.J. Purification and unique properties of mammary epithelial stem cells. Nature 2006, 439:993-997.
54. Su I.H., Basavaraj A., Krutchinsky A.N., Hobert O., Ullrich A., Chait B.T., Tarakhovsky A. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat. Immunol. 2003, 4:124-131.
55. Van Keymeulen A., Rocha A.S., Ousset M., Beck B., Bouvencourt G., Rock J., Sharma N., Dekoninck S., Blanpain C. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011, 479:189-193.
56. Varambally S., Cao Q., Mani R.S., Shankar S., Wang X., Ateeq B., Laxman B., Cao X., Jing X., Ramnarayanan K., et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008, 322:1695-1699.
57. Visvader J.E. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev. 2009, 23:2563-2577.
58. Wang L., Jin Q., Lee J.E., Su I.H., Ge K. Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis. Proc. Natl. Acad. Sci. USA 2010, 107:7317-7322.
59. Wei Y., Chen Y.H., Li L.Y., Lang J., Yeh S.P., Shi B., Yang C.C., Yang J.Y., Lin C.Y., Lai C.C., Hung M.C. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat. Cell Biol. 2011, 13:87-94.
60. Wu S.C., Zhang Y. Cyclin-dependent kinase 1 (CDK1)-mediated phosphorylation of enhancer of zeste 2 (Ezh2) regulates its stability. J. Biol. Chem. 2011, 286:28511-28519.
61. Zeidler M., Varambally S., Cao Q., Chinnaiyan A.M., Ferguson D.O., Merajver S.D., Kleer C.G. The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells. Neoplasia 2005, 7:1011-1019.